目的:探讨焦虑症患者和抑郁症患者的MMPI特点差异。方法:采用明尼苏达人格测验(MMPI)检测37例焦虑症和63例抑郁症,与37例正常对照两两比较。结果:焦虑症组和正常对照组在F,Hs,D,Hy,Pd,Pa,Pt,Sc具有显著差异(Plt;0.01),Ma具有差异(Plt;0.05);抑郁症组与正常对照组在F,Hs,D,Hy,Pd,Pa,Pt,Sc,Si具有显著差异(Plt;0.01),Ma具有差异(Plt;0.05);焦虑症组与抑郁症组在Hs,Hy,Pt,Sc,Ma没有差异均高于正常对照,在F,Pd,Pa具有差异(Plt;0.05),D,Si具有显著差异(Plt;0.01)。结论:焦虑症患者和抑郁症患者MMPI特点存在异常;焦虑症和抑郁症之间MMPI特点具有共性亦存在差异。
ObjectiveTo evaluate the efficacy and safety of busprione in treatment of anxiety in patients with epilepsy. Methods122 patients with anxiety accompanied with epilepsy were collected from sep.15, 201 to June 30.2016 in the Department of Neurology in Heze Municipal Hospital, they were randomly divided into busprione group(61 cases)and alprazolam group(61 cases), and treated respectively for 6 weeks.Curative effect were evaluated by the Self-rating anxiety scale (SAS) and Hamilton anxiety scale (HAMA). Adverse reactions in two groups were recorded during the treatment. ResultsBusprione had same efficacy with alprazolam in anxiety accompanied with epilepsy, and its adverse reaction was milder. ConclusionBusprione is safe and effective for treating anxiety accompanied with epilepsy in short time.